Mar 3, 2017
Approval and Access: overcoming the final hurdle of drub development a free to attend webinar on Friday 10 March at 11:00 GMT. Follow the debate live on Twitter #PPwebinar. Hosted by DIA and Pharmaphorum and moderated by Andrew McConaghie of Pharmaphorum.com.
West Byfleet, United Kingdom - March 3, 2017 /PressCable/ —
Individuals who will attend free webinar will have the opportunity to learn from the biggest and brightest stars in the industry …from how science and innovation can make impacts healthcare industry to improving it using technology effectively and competitively
The medical field is one area that has seen remarkable growth and innovation in the European market as there have been great leaps in learning in different aspect of the health industry, which has resulted in great inventions. In fact, the European healthcare has been a flag-bearer in developing new drugs and medical care to create the world’s healthiest and longest-living society, which makes it an area where the possibilities of what can be accomplished are endless. However, many challenges are facing the industry in the emerging European market… countries are now looking at new ways of reforming the way healthcare is provided and run.
With a burning desire to dispel this disheartening concerns, and to educate and inspire professionals in the health industry, Pharmaphorum, in partnership with DIA, will be hosting a free expert panel webinar debating the best way forward for life sciences companies, payers, and providers in this emerging European market access paradigm. Renowned as a premier digital publisher of thought leadership relating to the pharmaceutical industry, Pharmaphorum is passionate about transforming minds and helping the healthcare industry in Europe grow in a fascinating way.
The event which is scheduled to hold on Friday, March 10, 2017, at 11 am GMT (12 pm CET) will be divided strategically into unique sessions, and will be anchored by four biggest and brightest stars in the health industry. They include:
— Professor Luca Pani, a faculty member of the University of Miami, is a medical doctor, specializing in psychiatry, pharmacology and molecular biology. Besides being an author of over one hundred and fifty scientific publications, he has served as Director General of the Italian Medicines Agency (AIFA) from 2011 to 2016. Currently, he is a Fellow of the National Research Council of Italy and also associated with the Faculty and the Department of Psychiatry and Behavioural Sciences of the University of Miami School of Medicine.
— Angelika Joos, an executive director of Global Regulatory Policy, MSD (Europe) Inc. is responsible for Regulatory Policy issues within Merck Sharp & Dohme’s Global Regulatory Affairs department since 2001 and heads their European Union office in Brussels. Besides overseeing activities in Europe, Middle East, Africa, and Asia-Pacific and actively identifying opportunities that align with Merck Sharp & Dohme’s business priorities, Joos monitors and implements regulatory policies & procedures and advises her company on regulatory strategies.
— Andrew McConaghie, Pharmaphorum’s managing editor, writes on a range of topics covering pharmaceutical and biotech R&D, marketing and market access, and issues affecting patients and global healthcare systems, especially the UK’s NHS.
— Ana Palma, a leader at Global HTA and Patient Access at Sobi in Belgium is a guru with many years of vast experience in the European market.
With the speakers’ vast experiences in the health industry, they are keen on sharing solutions about the alarming issues identified in different facets of the medical field and how their solutions. Some of the topics to be discussed include the importance of science and innovation for system change, the value of early engagement to define requirements for global development, Integrating HTA and regulatory strategy, regional variation and implication, and much more.
Interested individuals are advised to reserve a seat on Brighttalk channel at pharmaphorum sign up page. To make the event more interesting, relevant topics that will be explored at the upcoming DIA Euromeeting in Glasgow in March will be reviewed.
The pharmaphorum team concluded “In this tough environment, it is vital that the requirements for continuing medical innovation and market access are addressed early in the drug development process. Parallel scientific advice from HTA bodies and regulators is increasing to deliver tangible and successful strategies, but is the process smooth enough to overcome the challenges from both sides?”
For more information about the event, speakers, and to reserve a seat, visit pharmaphorum sign up page.
Contact:
Mark Plummer
# # #
Contact Info:
Name: Mark Plummer
Email: [email protected]
Organization: pharmaphorum media limited
Address: Rosemount House, Rosemount Avenue, West Byfleet, England KT14, United Kingdom
For more information, please visit http://pharmaphorum.com/
Source: PressCable
Release ID: 175007
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.